Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: A phase II trial of celecoxib and docetaxel Article

Csiki, I, Morrow, JD, Sandler, A et al. (2005). Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: A phase II trial of celecoxib and docetaxel . CLINICAL CANCER RESEARCH, 11(18), 6634-6640. 10.1158/1078-0432.CCR-05-0436

Open Access

cited authors

  • Csiki, I; Morrow, JD; Sandler, A; Shyr, Y; Oates, J; Williams, MK; Dang, T; Carbone, DP; Johnson, DH

sustainable development goals

authors

publication date

  • September 15, 2005

published in

keywords

  • 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE
  • CARBOPLATIN
  • COX-2
  • EXPRESSION
  • GROWTH-FACTOR RECEPTOR
  • IN-VITRO
  • INHIBITORS
  • Life Sciences & Biomedicine
  • MAJOR URINARY METABOLITE
  • Oncology
  • PROSTAGLANDINS
  • QUANTIFICATION
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • AMER ASSOC CANCER RESEARCH

start page

  • 6634

end page

  • 6640

volume

  • 11

issue

  • 18